Antihypertensive Medication Use, Adherence, Stops, and Starts in Canadians With Hypertension

Canadian Journal of Cardiology

Volumn 28, Issue 3, 2012, Pages 383-389

  Gee, Marianne E ^a   Campbell, Norm R C ^b   Gwadry Sridhar, Femida ^c   Nolan, Robert P ^d   Kaczorowski, Janusz ^e   Bienek, Asako ^a   Robitaille, Cynthia ^a   Joffres, Michel ^f   Dai, Sulan ^a   Walker, Robin L ^g  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f SIMON FRASER UNIVERSITY   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CANADA; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HOME MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; SELF MEDICATION; SELF REPORT;

ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; BLOOD PRESSURE DETERMINATION; CANADA; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT DROPOUTS; RISK ASSESSMENT; RURAL POPULATION; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; URBAN POPULATION; YOUNG ADULT;

EID: 84860919160     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.01.014     Document Type: Article

References (28)

1. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks 2009, 1-62. World Health Organization, World Health Organization, Geneva, Switzerland.
2. Heidenreich P.A., Trogdon J.G., Khavjou M.A., et al. AHA policy statement: forecasting the future of cardiovasular disease in the United States. Circulation 2011, 123:933-944.
3. Gaziano T.A., Bitton A., Anand S., Weinstein M.C. The global cost of nonoptimal blood pressure. J Hypertens 2009, 27:1472-1477.
4. Kearney P.M., Whelton M., Reynolds K., Whelton P.K., He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004, 22:11-19.
5. Kotchen T.A. The search for strategies to control hypertension. Circulation 2010, 122:1141-1143.
6. Lewanczuk R. Innovations in primary care: implications for hypertension detection and treatment. Can J Cardiol 2006, 22:614-616.
7. Adherence to Long-Term Therapies: Evidence for Action 2003, World Health Organization, World Health Organization, Geneva, Switzerland.
8. McAlister F.A., Wilkins K., Joffres M., et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011, 183:1007-1013.
9. Campbell N.R., Onysko J. The Outcomes Research Task Force and the Canadian Hypertension Education Program. Can J Cardiol 2006, 22:556-558.
10. Survey on Living with Chronic Diseases in Canada: User Guide Statistics Canada, Accessed December 15, 2011. http://www.statcan.gc.ca/imdb-bmdi/document/5160_D4_T1_V1-eng.pdf.
11. Canadian Community Health Survey - Annual Component (CCHS) Statistics Canada, Accessed January 20, 2012. http://www.statcan.gc.ca/cgi-bin/imdb/p2SV.pl?Function=getSurvey&SDDS=3226&lang=en&db=imdb&adm=8&dis=2.
12. Caro J.J., Speckman J.L., Salas M., Raggio G., Jackson J.D. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ 1999, 160:41-46.
13. Bourgault C., Senecal M., Brisson M., Marentette M.A., Gregoire J.-P. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. J Hum Hypertens 2005, 19:607-613.
14. Caro J.J., Salas M., Speckman J.L., Raggio G., Jackson J.D. Persistence with treatment for hypertension in actual practice. CMAJ 1999, 160:31-37.
15. Cutler D.M., Everett W. Thinking outside the pillbox-medication adherence as a priority for health care reform. N Engl J Med 2010, 362:1553-1555.
16. Vawter L., Tong X., Gemilyan M., Yoon P.W. Barriers to antihypertensive medication adherence among adults-United States, 2005. J Clin Hypertens (Greenwich) 2008, 10:922-929.
17. Burke T.A., Sturkenboom M.C., Lu S., Wentworth C.E., Lin Y., Rhoads G.G. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006, 24:1201-1208.
18. Campbell N.R., Sheldon T. The Canadian effort to prevent and control hypertension: can other countries adopt Canadian strategies?. Curr Opin Cardiol 2010, 25:366-372.
19. Joffres M.R., Hamet P., MacLean D.R., L'Italien G.J., Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001, 14:1099-1105.
20. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497.
21. Schroeder K., Fahey T., Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care?. Systematic review of randomized controlled trials. Arch Intern Med 2004, 164:722-732.
22. Cappuccio F.P., Kerry S.M., Forbes L., Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ 2004, 329:145-150.
23. Shi L., Liu J., Fonseca V., Walker P., Kalsekar A., Pawaskar M. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes 2010, 8:99.
24. Zeller A., Ramseier E., Teagtmeyer A., Battegay E. Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators. Hypertens Res 2008, 31:2037-2043.
25. Garber M.C., Nau D.P., Erickson S.R., Aikens J.E., Lawrence J.B. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 2004, 42:649-652.
26. Friedman O., McAlister F., Yun L., Campbell N., Tu K. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario. Am J Med 2010, 123:173-182. Canadian Hypertension Education Program Outcomes Research Taskforce.
27. Wetzels G.E.C., Nelemans P., Schouten J.S., Prins M.H. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens 2004, 22:1849-1855.
28. Robitaille C., Dai S., Waters C., et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ 2012, 184:E49-E56.